Akeso Announced the Inclusion in China’s National Reimbursement Drug List of Cadonilimab and Ivonescimab
HONG KONG, Nov. 28, 2024 /PRNe…
HONG KONG, Nov. 28, 2024 /PRNe…
HO CHI MINH CITY, Vietnam, Nov…
TOKYO, Nov. 28, 2024 /PRNewswi…
TURFAN, China, Nov. 28, 2024 /…
PHNOM PENH, Cambodia, Nov. 28,…
SEOUL, South Korea, Nov. 28, 2…
BRISBANE, Australia, Nov. 28, …
PARIS, Nov. 28, 2024 /PRNewswi…
HONG KONG, Nov. 28, 2024 /PRNe…
HONG KONG, Nov. 28, 2024 /PRNe…